Robert J. Hariri - 18 Dec 2020 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/s/ Joanne Wendy Kim as Attorney-In-Fact
Issuer symbol
BIVI
Transactions as of
18 Dec 2020
Net transactions value
$0
Form type
4
Filing time
28 Sep 2021, 16:25:50 UTC
Previous filing
28 Sep 2021
Next filing
07 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +95,900 $0.000000 95,900 18 Dec 2020 Common Stock 95,900 $13.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant.